TY  - BOOK
AU  - Mrazek,David
TI  - Psychiatric pharmacogenomics
SN  - 9780199323128
AV  - RM315 .M73 2010
U1  - 615/.788 22
PY  - 2010///
CY  - New York
PB  - Oxford University Press
KW  - Psychotropic drugs
KW  - Pharmacogenomics
KW  - Biotransformation
KW  - genetics
KW  - Psychotropic Drugs
KW  - adverse effects
KW  - Mental Disorders
KW  - drug therapy
KW  - pharmacokinetics
KW  - MEDICAL
KW  - Pharmacology
KW  - bisacsh
KW  - fast
KW  - Electronic books
N1  - Includes bibliographical references and index; The language of molecular genetics -- The fourteen genes -- The problem and the solution -- The cytochrome P450 2D6 gene -- The cytochrome P450 2C19 gene -- The cytochrome P450 2C9 gene -- The cytochrome P450 1A2 gene -- The catechol-o-methyltransferase gene -- The norepinephrine transporter gene -- The dopamine transporter gene -- The serotonin transporter gene -- The serotonin 1A receptor gene -- The serotonin 2A receptor gene -- The serotonin 2C receptor gene -- The dopamine D2 receptor gene -- The dopamine D3 receptor gene -- The dopamine D4 receptor gene -- The clinical utility of psychiatric pharmacogenomic testing -- Ethical issues to consider when using pharmacogenomic testing in psychiatric practice -- The future development of psychiatric pharmacogenomic testing
N2  - This is a book written to help clinicians to use pharmacogenomic testing to improve the pharmacotherapy that they provide for their patients. It is designed to teach clinicians how to order pharmacogenomic tests and interpret the results
UR  - https://libproxy.firstcity.edu.my:8443/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1204654
ER  -